Concepedia

Author

Andrew Buchanan

AstraZeneca (United Kingdom)ORCID

Also Known As

A. Buchanan, ANDREW BUCHANAN, Andrew Buchanan, Andrew G. Buchanan, Buchanan, Andrew

44

Publications

1.6K

Citations

19

H-Index

76

Concepts

All Affiliations

AstraZeneca (United Kingdom)AstraZeneca (Sweden)University of CambridgeRecombinant Antibody Technology (United Kingdom)Granta Design (United Kingdom)
AB

About

Andrew Buchanan is an author at AstraZeneca (United Kingdom) specializing in medicine, antibody engineering, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

788

2

Engineering

4

4

123

3

Business

1

1

17

4

Health Sciences

1

1

23

5

Law

1

1

17

Andrew Buchanan

×

25

Publications

1.5K

Citations

19

H-Index

YearCitations

Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody

Ross Stewart, Michelle Morrow, Scott A. Hammond,

Cancer Immunology Research

2015

398

Antibody–Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies

Jonathan Rios‐Doria, Jay Harper, Raymond Rothstein,

Cancer Research

2017

124

Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo

Claire Dobson, Paul W. A. Devine, Jonathan J. Phillips,

Scientific Reports

2016

120

DLAB: deep learning methods for structure-based virtual screening of antibodies

Constantin Schneider, Andrew Buchanan, Bruck Taddese,

Bioinformatics

2021

95

Structural and functional characterization of a specific antidote for ticagrelor

Andrew Buchanan, Philip M. Newton, S. KENNETH PEHRSSON,

Blood

2015

88

Computational Design of Epitope-Specific Functional Antibodies

Guy Nimrod, Sharon Fischman, Mark Austin,

Cell Reports

2018

80

Probing a protein–protein interaction by <i>in vitro</i> evolution

George Thom, Alexis C. Cockroft, Andrew Buchanan,

Proceedings of the National Academy of Sciences

2006

79

Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression

Andrew Buchanan, Veronica Clementel, Rob Woods,

mAbs

2013

73

Rapid discovery of high-affinity antibodies via massively parallel sequencing, ribosome display and affinity screening

Benjamin T. Porebski, Matthew Balmforth, Gareth J. Browne,

Nature Biomedical Engineering

2023

61

Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design

Daniel A. Cannon, Lu Shan, Qun Du,

PLoS Computational Biology

2019

58

Page 1